Search results
US FDA staff raise no major concerns about Eli Lilly Alzheimer's drug
Reuters via Yahoo News· 1 day agoAn FDA analysis of trial data for Eli Lilly's experimental Alzheimer's drug donanemab released on...
FDA Staff Proposes Narrow Approval for Lilly’s Alzheimer’s Drug
Bloomberg· 1 day agoUS drug regulatory staffers are considering a more targeted approval for Eli Lilly & Co.’s ...
In review of Lilly Alzheimer’s drug, FDA staff focus on safety, patient selection
BioPharma Dive via Yahoo Finance· 1 day agoThe agency is seeking input from an advisory panel on whether donanemab is effective across...
U.S. FDA places clinical hold on Biomea's diabetes trials
AOL· 19 hours agoThe drug developer said the FDA cited deficiencies based on the level of possible drug-induced toxic liver disease observed in the completed ...
Stakeholders blast FDA panel’s rejection of MDMA therapy
The Hill via AOL· 16 hours agoClick in for more news from The Hill {beacon} Health Care Health Care The Big Story Stakeholders...
Is Moderna Stock A Buy After Its Second-Ever Product Snags FDA Approval?
Investor's Business Daily· 3 hours agoModerna says it has finished dosing healthy participants in a Phase 1 and Phase 2 study of its ...
Panel rejects psychedelic drug MDMA as a PTSD treatment in possible setback for advocates
WKRN Nashville· 3 days agoWASHINGTON (AP) — A first-of-a-kind proposal to begin using the mind-altering drug MDMA as a...
FDA advisers reject MDMA therapy to treat PTSD
FOX 10 Phoenix· 2 days agoPanel members on Tuesday also pointed to allegations of impropriety occurring during clinical trials that were reported in news stories and by the...
‘Dead wrong’: Lawmakers, advocates decry rejection of MDMA-assisted therapy by FDA panel
The Hill via AOL· 22 hours agoA Food and Drug Administration (FDA) panel’s surprising recommendation this week to reject the use...
US FDA panel to vote on data, risk profile of Lilly Alzheimer’s drug
WHTC 1450 Holland· 1 day ago(Reuters) - A panel of outside experts to the U.S. health regulator will vote on Monday on whether...